share_log

BioCryst Pharmaceuticals | 424B5: Prospectus

SEC ·  Nov 21, 2019 09:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more